Sri Lankan Finger Millet (Elucine coracana) Variety ‘Raavana’ as Potential Probiotic Source by Divisekera, D M W D et al.
Evolving Industrial Biotechnology 
in Developing Countries
* v
X
V .*;a A
A
Editors
Lucy Ogbadu ■ Godwin Ogbadu 
Courtie Mahamadi
Chapter 16
Sri Lankan Finger Millet 
(Elucine coracana) Variety ‘Raavana’ as 
Potential Probiotic Source
D.M.W.D. Divisekera1 ,J.K.R.R. Samarasekera1, 
J. Goonerathne1, C. Hettiarachchi2 and S. Gopalakrishnan3
1Food Technology Section, Industrial Technology Institute, 
363, Bauddhaloka Mawatha, Colombo, 00700 SRI LANKA
E-mail: mb.wasu@gmail.com 
2Faculty o f Science, University o f  Colombo, SRI LANKA 
international Crops Research Institute for  the Semi-Arid Tropic,
Telangana, INDIA
ABSTRACT
This study aims to isolate and identify probiotic potential lactic acid bacteria from 
fermented Sri Lankan finger millet variety "Raavana" and to investigate the probiotic 
characteristics, in vitro safety and efficacy. A bacterial isolate with typical lactic acid bacterial 
phenotypic and biochemical characteristics was isolated and identified. Partial sequence of the 
16S rRNA gene of the Sri Lankan strain was deposited in the NCBI gene bank as Lactococcus 
lactis subsp. lactis FM_19LAB and the accession number MF480428 was obtained. It did 
not demonstrate hemolysis, DNase, gelatine hydrolysis activity as well as did not acquire 
complete resistance to any of the antibiotics tested hence indicating the safety. Lactococcus 
lactis subsp. lactis FM_19LAB had the capacity to tolerate different concentrations of acid, 
bile, phenol, salt, simulated gastric juices and range of temperatures. Further it exhibited 
anti-microbial, anticancer and anti-oxidant activities. Further, Lactococcus lactis subsp. lactis 
FM_19LAB assimilated cholesterol and produced lactic acid during the fermentation.
Keywords: Sri Lankan finger millet, Lactococcus lactis subsp. lactis FM_19LAB, Probiotics, 
Prebiotics.
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INTRODUCTION
Probiotics are defined as "live microorganisms, which when administrated in 
adequate amounts confer a health benefit on the host" by the Food and Agriculture 
Organization/World Health Organization (FAO/WHO 2006). Lactic Acid Bacteria 
(LAB) are widely recognized among probiotic bacteria that are gram positive 
non-spore forming and catalase negative organisms. The beneficial effects include 
promoting gastrointestinal and genitourinary health-improving the immune system 
managing irritable bowel syndrome and inflammatory bowel diseases, reducing ff. 
pylori associated gastric ulcers, and improving constipation (Bergonzelli et a l ,  2006; 
D'Souza et a l ,  2002; Whelan et a l,  2013; Koebnick et al., 2003). Lactic acid bacteria 
(LAB), if functional as a probiotic it should exhibit resistance to acid, bile and gastric 
juices, adhere and colonize in-gastric mucosa (Kos et al., 2003), exhibit co-aggregation 
preventing colonization by pathogens (Collado et a l, 2008) and efficacy to host which 
support their use as alternative therapy. Therefore, probiotic LABs are increasingly 
recognized in food industrial applications. As a result, novel bacterial strains with 
probiotic properties are been introduced in to food and pharmaceutical market 
particularly in dairy products (Penna et a l,  2007). Currently consumer demand 
exists for non-dairy probiotic products in beverages, supplements, capsules and 
freeze-dried preparations (Schrezenmeir and de Vrese, 2001). Therefore, cereals 
rich in prebiotics play a major role as substrate for many non-dairy probiotic 
products. Finger millet (Eleusine coracana) is known since ancient times and rich 
in carbohydrates, dietary fibre, minerals, and sulfur containing amino acids when 
compared with rice, the current major staple in south Asia (Sripriya et a l ,  1994). 
Fermentation of finger millet using different starter cultures to develop functional 
foods has been extensively reported in Africa and Asia (Charalampopoulos et al, 
2002). Due to the presence of water-soluble fibres, oligosaccharides and resistant 
starch, it fulfils the prebiotic effects and therefore can stimulate the growth of 
probiotic bacteria. Though, plenty of research available on prebiotic and probiotic 
potential of finger millet varieties grown on different regions in the world, there is 
a paucity of data on Sri Lankan scenario. Furthermore, due to the increasing interest 
m the application of probiotics and their metabolites as an alternative strategy 
for treatment and prevention of infections, antimicrobial activity against human 
pathogens is an important property of a potential probiotic candidate. In addition, 
antimicrobial metabolites of probiotic LAB in preventing food spoilage, extending 
the shelf life stability of food and enriching the food with bioactive properties are 
the challenges facing food industry today. The objective of the research was to 
isolate probiotic potential organisms associated with Sri Lankan finger millet variety 
Raavana' and to explore its' probiotic potential through series of experiments at 
the industrial technology institute of Sri Lanka.
Materials and Methods
Collection and Processing of Finger Millet Sam ples
Sri Lankan finger millet (Elucine coracana) variety namely Raavana was selected 
for the present study. Seeds of the variety represented the six different provinces
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f the island including North, North Central, Eastern, Southern, Sabaragamuva 
and Uva, were obtained from the germplasm of the Field Crop Research and 
pevelopment Institute (FCRDI), Mahailluppallama. The seeds were transported 
to the Microbiology Laboratory, Industrial Technology Institute (ITI) within 3 h 
ky maintaining the temperature at 20 ± 2 °C. Samples were washed with sterilized 
distilled water inside a Biological safety cabinet (Thermoforma,USA) and dried at 35 
± 2 °C in an oven (Memmert Universal Oven U, Germany) till the moisture content 
reduced to 10 per cent. The moisture content of the samples was measured by drying 
the samples at 105 ± 2 °C in an oven (Memmert drying oven UF, Germany) for 5 h 
and calculated the water loss. Each dried sample was ground in a variable Speed 
Rotar Mill (Fritsch PULVERISETTE 14, Germany) and passed through a 0.5 mm 
sieve attached to the mill. The milled and sieved samples were packed separately in 
air tight containers and stored in cold room (Viessmann Tecto compact 80, Finland) 
at 12 ± 2 °C till use.
Fermentation of Finger Millet Sam ples
Six samples (n=6) containing 25 g of each was measured and transferred in to 
pre-sterilized glass beakers covered with aluminium foils. The flour samples were 
mixed with sterilized tap water in 1:3 (w/v) ratios to prepare the batter. The batters 
were allowed to ferment inside a biological safety cabinet at room temperature (24 
± 3 °C) for 18 h.
Isolation of Probiotic Potential Lactic Acid Bacteria from Fermented 
Finger Millet
Each fermented sample was serially diluted up 106 in sterilized physiological 
saline (0.9 per cent NaCl w/v). Isolation was carried out by following both spread 
plate and pour plate technique in duplicates. Both pour and spread plates were 
incubated at 37 ± 1 °C for 24 h.
Phenotypic Characterization of Lactic Acid Bacteria
Colonies appeared on MRS agar plates were picked carefully and streaked 
on fresh MRS agar plates. The plates were incubated at 37 ± 1 °C for 24 h. After 
•ncubation, colony morphology of isolates such as form, size, shape, surface, texture, 
color, elevation and margin were recorded. Gram staining, endospore staining and 
motility test was performed to differentiate the isolates based on their phenotypic 
characteristics (Aswathy et al., 2008).
biochem ical Characterization of Isolates
Biochemical tests including indole, methyl red, vogeus prosker, citrate utilization, 
gelatin liquefaction, H2S production, starch hydrolysis, urease and catalase were 
Performed to characterize isolates. Sugar fermentation pattern of potential LAB 
isolates were investigated in triplicate (n=3) for sixteen different sugars; glucose, 
fructose, maltose, lactose, galactose, melezitose, melibiose, arabinose, ribose, sucrose, 
Salicinsorbitol, mannitol, cellulose, cellobiose and dextrose.
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In vitro Safety Attributes of the Newly Isolated Probiotic Isolates 
Bile Salt Hydrolysis (BSH) Test
Bile Salt Hydrolysis screening medium was prepared by supplementing MR§ 
agar with (0.5 per cent porcine bile w/v, 0.5 per cent sodium tauroglycocholate 
w/v, 0.5 per cent taurodeoxycholic acid sodium Salt w/v and 0.37 CaCl2 g/1. The 
media was sterilized for 121 ± 1°C for 15 min and poured in to sterile Petri plates 
in triplicates and allowed to solidify. Cell density of each test bacterial isolate was 
adjusted to 105cfu/ml. From each culture, 10 pi were spotted on BSH screening media 
plates. Plates were incubated at 37 ± 1°C for 72 h. BSH activity was determined by 
observing and measuring the precipitation zones.
Hemolysis Test
Blood agar base (Himedia, India) was prepared and sterilized at 121 ± 2 °C for 
15 min. The sterilized media was cooled up to 50 ± 1°C and supplemented with 5 
per cent sheep blood (v/v) aseptically followed by mixing; the media was poured 
in to sterile petri plates and allowed to solidify. Six colonies (n=6) from each test 
bacterial isolate was inoculated in to blood agar plates followed by streaking. 
The plates were incubated at 37 ± 1 °C for 72 h. After incubation, the plates were 
observed for presence of hemolysis zones (|3-hemolysis- clear zone of hydrolysis 
of blood cells around the colonies, a-hemolysis- green zone around the colonies, 
y-hemolysis- no clear or no green zone around the colonies). Haemolysing strain 
Streptococcus pyogene ATCC 19615 was used as the positive control.
DNase Test
DNase agar was prepared and sterilized at 121 ± 2 °C for 15 min. Six colonies 
(n=6) from each bacterial isolate was spotted on the surface of the DNase agar plates. 
The plates were incubated at 37 ± 1 °C for 18 h and observed for thick plaque of 
growth around the colonies. Pathogenic strain Serratia marcescens ATCC 13880 was 
used as the positive control.
Gelatin Hydrolysis
TND agar containing 1.7 per cent tryptone (w/v), 0.3 per cent peptone (w/v), 
0.25 per cent dextrose (w/v), 0.5 per cent NaCl (w/v), 0.25 per cent K2H P 04 (w/v),
1.5 per cent agar (w/v) and 0.4 per cent gelatine bacteriological (w/v) was p re p a re d  
and sterilized for 121 ± 1 °C for 15 min. Sterilized media was poured in to sterile 
plates and allowed to solidify. Cell density of each test probiotics was adjusted to 
105cfu/ml. From each culture, lOpl were spotted on TND agar plates in triplicates. 
Plates were incubated at 37 ± 1 °C for 72 h. After incubation, the plates were treated 
with saturated solution of ammonium sulphate and observed for the clear zones 
around the inoculated spot against the opaque background. Gelatine hydrolysing 
strain Serratia marcescens ATCC 13880 was used as the positive control.
Evaluation of the In vitro Probiotic Attributes of Newly Isolated 
Potential LAB
The newly isolated LAB were further investigated for its' ability to grow in
the presence of acid, bile, salt, phenol, temperature and gastric juice (Aswathy et 
I 2008). Isolates were inoculated into sterile MRS broth tubes and incubated at 37 
* "i °C for 18 h. After incubation, the tubes were centrifuged at 10,000 x g  at 4 ± 1 
oQ for 15 min. Subsequently the pellet was washed with sterile saline solution and 
ceritrifuged at 10,000 x g  at 4 ± 1 °C for 15 min. Finally, the pellets were dissolved 
^  10 ml of MRS broth and adjusted to 0.5 Macfarl and turbidity standards to use 
in the tolerance tests.
For acid tolerance assay, MRS broth tubes were sterilized and pH was adjusted 
t0 2,3 , and 4 using 1 M HC1. The pH adjusted broths were inoculated with 100 pi 
of each test bacteria (n=3). For bile tolerance assay, MRS broth tubes were adjusted 
with 0.2 per cent, 0.5 per cent, 1.0 per cent, 1.5 per cent and 2.0 per cent porcine Bile 
(w/v). TTie media were sterilized by filtering through 0.45 pm diameter syringe 
filters. Sterilized media were inoculated with 100 pi of each test bacteria (n=3). For 
simulated gastric juice tolerance assay, simulated gastric juice was formulated using
3.5 g/1 glucose, 2.05 g/1 NaCl, 0.60 g/1 KH2P 0 4, 0.11 g/1 CaCl2, 0.37 g/1 KC1. The 
pH of the mixture was adjusted to 2 by 1M HC1 (Corcoran et al., 2005). The mixture 
was sterilized for 121 ± 1 °C at 15 min. Prior to analysis 0.05 g/1 porcine bile, 0.10 g/1 
lysozyme, and 0.10 g/1 pepsin, were added to stock solution. The simulated gastric 
juice solution was sterilized by filtering through 0.45 pm diameter syringe filters. 
Subsequently 100 pi of each test bacteria were inoculated in to the tubes containing 
sterile simulated gastric juice (n=3). For salt tolerance assay (Menconi et al., 2014) 
MRS broth tubes were prepared and adjusted to 4 per cent, 5 per cent, 8 per cent 
and 12 per cent (w/v) with NaCl. The media was sterilized at 121 ± 1 °C for 15 min. 
Aseptically 100 pi of each test bacteria were inoculated in to the MRS broth tubes 
and adjusted to different salt concentrations (n=3). For phenol tolerance assay MRS 
broth were prepared and adjusted to 0.1 per cent, 0.2 per cent, 0.3 per cent, 0.4 per 
cent and 0.5 per cent phenol (v/v) separately (Aswathy et al., 2008). The media were 
sterilized for 121 ± 1 °C at 15 min. Inoculated 100 pi of each test bacteria in to the 
MRS broth tubes adjusted in to different phenol concentrations (n=3). All the assay 
tubes were mixed for 30 sec. Under aseptic condition, 200 pi of each test sample 
was loaded into 9 wells of the microplate and initial cell density was measured 
spectrophotometrically at 620 nm and the cell densities of the experimental wells 
Were measured hourly at 1, 2 ,3 ,4 ,5  and 6 h intervals.
For temperature tolerance assay, MRS broth was dispensed equally in to tubes 
and sterilized. The tubes were inoculated with 100 pi of each test bacteria (n=3). 
Under aseptic condition, 200 pi of each test sample was loaded into 3 sterile micro 
Plates where in each plate 9 wells were loaded from same inoculums (n=9). Initial cell 
density was measured spectrophotometrically at 620 nm and the three plates were 
incubated at three different temperature 30 ± 1 °C (Memmert INC 153, G), 37±1°C 
(Gemmyco IN-010, France) and 42 ± 1 °C (MemmertlNplus, Germany), respectively 
for 6 h. Cell density was measured hourly at 1,2 ,3 ,4 ,5  and 6 h intervals.
Among the isolates, an isolate with superior probiotic attributes was selected 
for molecular identification.
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Molecular Characterization of Potential Lactic Acid Bacteria I s o l ^  
Extraction of Genomic DNA
Test isolate was inoculated in to sterilized MRS broth tubes and incubated at 
37 ± 1 °C for 24 h. after incubation; 2 ml of the inoculums was transferred in to 2 5 
ml micro centrifuge tubes and centrifuged at 14000 x g  at 4 ± 1 °C for 2 min. t]le 
supernatant was separated without disturbing the pellets and 200 pi of Tris EDT^ 
buffer was added to pellet followed by centrifugation at 14000 x g  at 4 ± 1 °C f0r j  
min. Supernatant was discarded and the pellet was re-suspended in 200 pi Tris EDT^ 
buffer and added 10 pi of 100 pg/pi (w/v) Proteinase K enzyme. Subsequently ig 
pi of 10 per cent Sodium Dodecyl Sulfate was added and mixed thoroughly. The 
reaction tube was incubated in a water bath at 50 ± 1 °C for 1 h. After incubation 
110 pi of phenol and 110 pi of chloroform were added and centrifuged at 14000 x g 
at 4 ± 1 °C for 2 min. Aqueous layer (approximately 150 pi) was separated without 
disturbing the organic layers. To the organic layer, 30 pi of >99.8 ethanol (v/v) 
and 15 pi of 3 M sodium acetate were added. The tube was mixed by vortexing 
and incubated in ice for 1 h. After incubation, the tube was centrifuged at 14000 x 
g  at 4 ± 1 °C for 5 min. Supernatant was discarded and 1 ml of 70 per cent ethanol 
(v/v) was added to the tubes and mixed by inverting several times followed by 
centrifugation at 14000 x g  at 4 ± 1 °C for 5 min. Supernatant was discarded and 
ethanol was evaporated and the pellet was dissolved in 40 pi of PCR water and 
stored at -20 ± 2 °C (Shahriar et al., 2011 modified). The extracted genomic DNA 
was quantified using gel documentation system (Gel Doc™ XR+ BIO RAD, USA).
Polymerase Chain Reaction (PCR)
Bacterial DNA was amplified by Dr. MAX DNA Polymerase using DNA Engine 
Tetrad 2 Peltier Thermal Cycler (BIO-RAD, UK) at MACROGEN, South Korea (www. 
macrogen.com). Universal primers 27F (5c-AGAG l 1 1GATCCTGGCTCAG -3c) and 
1492R (5c-GGTTACCTTGTTACGACTT -3c) were used as forward and reverse 
primers, respectively. The PCR was performed under the following thermocycler 
program; Initial denaturation at 95 ± 1 °C for 5 min followed by denaturing step 
conducted in 35 cycles at 95 ± 1 °C for 30 sec. Annealing of the primers to the single 
stranded DNA template was done at 55 ± 1 °C for 30 sec. Elongation was conducted 
at 72 ± 1 °C for 1 min; the final elongation was carried out at 72 ± 1°C for 10 min. 
The PCR products were purified using multiscreen filter plate (Millipore Corp, UK).
Sequencing of 16S rRNA Region
Sequencing of 16S rRNA region was performed using 96 capillary type ABI PRISM 
3730XL Analyzer (UK). Forward primer 5' TGTCGTGAGATGTTGGGTTAAGTC 3' 
and Reverse primer 5' CGGTATTAGCATCTGTTTCC 3' were used. Purified PCR 
product was sequenced at MACROGEN, South Korea in a thermocycler program 
consisting of initial denaturation at 96 ± 1 °C for 1 min followed by 25 cycles at 96 ±
1 °C for 10 sec. Annealing was done at 50 ± 1 °C for 4 sec followed by elongation at 
60 ± 1 °C for 4 min; and hold at 4 ± 1 °C. DNA sequences were obtained as FASTA 
format were compared with those from GenBank (http://www.ncbi.nlm.nih. 
gov) using the Basic Local Alignment Tool (http://www.ncbi.nlm.gov/BLAST/).
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c^quence with a percentage of identity of 98 per cent or higher to those in databases 
,^ere allocated to the same species. The sequence was aligned using the Clustal W 
pUiltiple sequence alignment program (Thompson et al., 1997). The 16S rRNA gene 
gequences of potential probiotic isolate was submitted to NCBI (http: / / www.ncbi. 
nlm-nih.g°v) and GenBank accession number was obtained.
Investigating A ntibiotic Su sceptib ility  of Potential Probiotic by 
Alamar Blue Cell Viability Assay
Newly isolated probiotic strain was investigated for their susceptibility to 24 
different antibiotics including netilmicin, amikacin, gentamycin, ofloxacin, cefoxitin, 
doxycycline, sulbactam, neomycin, ampicillin, vancomycin, oxacillin, streptomycin, 
penicillin, nitrofurantoin, sulfamethoxazole, chloramphenicol, trimethoprim and 
clindamycin. Antibiotic solutions were prepared at a concentration of 100 pg/ml 
(w/v) by dissolving the above antibiotics in sterilized distilled water followed by 
filtering through 0.22 pm syringe filters. Potential probiotic isolate was adjusted 
to 0.5 McFarland turbidity standards and stored at 4±1 °C until use. Antibiotic 
susceptibility was measured spectrophotometrically by performing Alamar blue 
assay. Each test antibiotic solution in a volume of 20 pi was aseptically added to 
the wells (n=9) of the sterile 96 well plate. Subsequently 173 pi of sterile MRS broth 
was added to all the wells followed by test probiotics (each 7 pi). Micro plates were 
sealed with parafilm and incubated at 37 ± 1 °C for 20 h. After incubation, 20 pi of 
Alamar blue cell viability reagent® was added to all the wells in dark environment. 
The plates were covered with aluminum foils and incubated in a shaker (CPS-350, 
Korea) at 30 ± 1 °C for 2 h at 100 x g. After incubation, the wells were sealed and 
absorbance were measured (Spectra Max plus, USA) at both A.=570 nm and A,=600 
nm. Negative control was performed omitting antibiotics and replacing the volume 
with 193 pi of MRS broth.
Percentage inhibition of test probiotics by antibiotics was calculated by
(eox) = molar extinction coefficient of Alamar blue oxidized form (blue)
(ered) = molar extinction coefficient of Alamar blue reduced form (pink)
A = absorbance of test wells
A2 = absorbance of negative control well
Xj = 570 nm, and X2 = 600 nm.
investigating In vitro Anti-microbial Activity by Well Diffusion Assay
Ten strains of drug sensitive and five strains of Multi Drug Resistant (MDR) 
Pathogens were obtained from Microbial Bank of PCMD, ICCBS University of 
Karachi, Pakistan. These strains were Escherichia coli ATCC 2592, Escherichia coli 
A T r r  ^^91 s /MDRi Stanhulacoccus aureus ATCC 6571, Staphylococcus aureus EMRSA
following formula.
Per cent inhibition =
(£Ox)JL2A3tl -  I sox  iA1AA2
where,
17 COCR (MDR), Staphylococcus aureus EMRSA 16 NCTC 13143 (MDR), Klebsie/ 
pneumonia ATCC 35594, Klebsiella pneumonia ATCC 700603 (MDR), Enterococcu 
faecalis ATCC 49532, Enterococcus faecalis ATCC 700802 (MDR), Streptococcus mutan 
ATCC 25175, Streptococcus pyogenes ATCC 700294, Streptococcus sanguinis ATCq 
10556, Streptococcus salvarius ATCC 13419, Salmonella enterica ATCC 700408 (MDR) 
Acinetobacter baumannii ATCC 17978 and Shigella flexneri ATCC 12022. The welj 
diffusion assay was conducted according to Naderi et a l,  2013 with modifications 
Probiotic isolate was adjusted to 0.5 McFarland turbidity standards. Soft agar was 
melted and at 45 ± 2 °C, 100 pi of each pathogenic culture was added to separate 
soft agar tubes in triplicates and poured on to the solidified agar plates (n=3). Plates 
were rotated to evenly distribute the culture and allowed to solidify. By using 
sterile 6 mm diameter borer, wells were made on the solidified plates; wells were 
clearly marked and 100 pi of probiotic inoculums was added to the well (n=9). The 
plates were sealed and incubated at 37 ± 1 °C for 24 h. Disc of 10 pg concentration 
of imipenem was used as the control. After incubation, the inhibition zones were 
measured using a calibrated scale. Antimicrobial activity was expressed as the 
diameter of the inhibition zones in mm around the wells.
Investigating In vitro Anticancer Activity by MTT Assay
Anticancer activity of potential probiotic was evaluated against two Colon 
cancer cell lines namely HCT 116 and HT 29.
To prepare the Cell free extract (CFE), isolate was inoculated in to sterile MRS 
broth followed by incubation at 37 ± 1 °C for 18 h. After incubation, the tubes were 
centrifuged at 11,000 x g  for 30 min at 4 ± 1 °C. The supernatants were sterilized by 
passing through 0.22 pm syringe filter. The CFE was stored at 4 ± 1 °C until use. 
To prepare Cell Free Lyophilate (CFL), the CFS of test probiotic was freeze dried 
(Lablyo HSL 4, UK) by storing the CFE at -20 ± 1 ° C for 10 h initially and transferred 
to freeze drier for 45 h with 10 min initial freezing followed by 40 h of primary 
(when internal pressure reduced to -100 torr) and 5 h of secondary freezing at -80 
± 2 °C. The resulted CFL was stored at -20 ± 1 °C until use.
Dulbecco's Modified Eagle's Medium (DMEM) was used to maintain the cell 
lines. DMEM was prepared by supplementing DMEM F-12 with 10 per cent Fet al 
Bovine Serum (v/v), 1 per cent 1-glutamine (v/v), 1 per cent penicillin-streptomycin 
solution (v/v) and 7.5 per cent NaHC03. The medium was sterilized by filtration 
and stored at 4 ± 1 °C until use.
The cryo vials containing two different cell lines were reviewed in DMEM 
flasks and incubated (Nuaire NU-8700E, USA) at 37 ± 1 °C with 5 per cent COzfor 
24 h. The flasks were observed through microscope for the 80 per cent confluence. 
Cell viability was determined by MTT assay. HT 29 and HCT 116 cell lines were 
inoculated separately in to wells (n=9) of 96 well plate at a concentration of 15 * 
103 cells/well. Probiotic CFE (5, 25, 50, 250 and 500 pl/ml) and CFL (750 pg/ml, 
1250 pg/ml, 2500 pg/ml, 3750 pg/ml, 5000 pg/ml and 7500 pg/ml) at different 
concentrations were investigated for their anti-cancer assay. Plates were incubated 
at 37 ± 1 °C for 24 h with 5 per cent C 0 2 After incubation, the media were discarded
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d iOO pi of MTT solution (3-[4,5-dimethylthiazol-2-yl]-2,5- diphenyl tetrazolium 
^oinide thiazolyl blue; 5 mg/ml in sterile PBS) was added to all the wells. The 
bj3tes were incubated for 2 h at 37 ± 1 °C with 5 per cent CO, After incubation, 100 
*Yof Dimethyl sulfoxide was added and the plates were shaked to dissolve the blue 
^ygtals. The absorbance of plates was measured at X=570 nm.
The percentage anticancer activity (per cent) was calculated using following 
formula,
. . . . M eanODtreatment
Percentage anticancer activity (per cent) = M ean O D con tro i x  100
The cell viability of controls were calculated using following formula,
M eanODcontrol
Percentage cell viability of controls = M e a n 0 D c o n tr o l  *  100
Where,
Mean OD treatment = Mean value of the OD of treatment well at A=570 nm
Mean OD control = Mean value of the OD of control well at X=570 nm
Cetuximab was used as the positive control with CFE experiment (Lancet, 
2011). The half maximum inhibitory concentration (IC50) of both CFE and CFL of 8 
probiotics were calculated by drawing individual scatter plots with linear regression.
Investigating In vitro A n tioxid ant A ctivity  by DPPH R ad ical 
Scavenging Assay
The 2, 2-diphenyl-l-picrylhydrazyl (DPPH) radical scavenging activity was 
measured by mixing 140 pi of each CFE with 60 pi of freshly prepared DPPH solution 
(7 mg/100 ml methanol). Each probiotic was tested for series of concentrations 
including 5, 25, 50, 250 and 500 pi/ml CFE in PBS. Immediately the absorbance 
was measured at X= 517 nm. The reaction mixture was allowed to stand for 30 
min. Trolox was used as positive control. The scavenged DPPH was evaluated by 
measuring the reduction in absorbance at 517 nm.
Similarly, probiotic CFL was dissolved in 25 per cent acetone to prepare the 
concentrations of 10,000 pg/ml, 20,000 pg/ml and 50,000 pg/ml. Immediately the 
absorbance was measured at X= 517 nm. The reaction mixture was allowed to stand 
for 1 hr. Trolox was used as positive control. The scavenged DPPH was evaluated 
by measuring the reduction in absorbance at 517 nm.
The scavenging ability was calculated by following formula:
A 517 (sa m p le )
Per cent inhibition = 1 ^4517 ( b l an k )  X
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where,
A517 (sample) = Absorbance of sample at 517 X 
A517 ('blank') = Absorbance of blank at 517 A.
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Investigating the In vitro Cholesterol Assimilation
The cells of probiotic culture were adjusted to O D ^ (1010cfu/ml). Modified 
MRS broth was prepared by mixing 0.3 per cent (w/v) porcine bile and 0.1 g/j 
cholesterol-water soluble in to MRS broth and adjusted the final concentration of 
cholesterol in the media in to 100 mg/1.1 ml (1010cfu) of the probiotic culture was 
transferred in to tubes containing 5 ml of modified MRS broth (n=3). Tubes were 
incubated at 37 ± 1 °C for 24 h. After incubation, the tubes were centrifuged at 4500 
x g  at 4 ± 1 °C for 5 min. Supernatants (test) and un inoculated Modified MRS broth 
(control) were assayed for cholesterol.
Each supernatant of 1 ml volume was mixed with 3 ml 95 per cent ethanol and
2 ml of 50 per cent (w/v) potassium hydroxide. The mixture was heated at 60 + 1 
°C for 10 min in water. After cooling, 5 ml of hexane was added in to each tube and 
mixed thoroughly. Subsequently, 1 ml of distilled water was added to all the tubes 
followed by mixing and allowed to stand for 10 min to permit phase separation. 
A 3 ml aliquot of hexane layer from each tube was transferred in to clean tubes. 
Evaporation of hexane was done under the flow of nitrogen gas. O-phtalaldehyde 
(0.5 mg/ml of acetic acid) solution was freshly prepared and 4 ml was added 
to each tube. The tubes were allowed to stand for 10 min. Subsequently, 2 ml of 
concentrated H2S 0 4 was added to each tube and allowed to stand for another 10 min. 
The absorbance of reaction mixture was measured at 550 nm. A standard curve of 
absorbance verses cholesterol concentrations was generated using the cholesterol 
concentrations; 0, 2.91, 7.81,15.63, 31.25, 62.5,125, 250 and 500pg/mL cholesterol 
in MRS (R2=0.99). The cholesterol assimilated by test probiotic was calculated using 
following formula;
Cholesterol assimilated (pg/mL) = [Cholesterol (pg/mL)]oh-[Cholesterol (pg/ 
mL)]24h
Cholesterol assimilated by each test probiotic strain was also calculated in 
terms of percentage cholesterol assimilation;
[Cholesterol assimilated 
cholesterol (pg/mL)]
Per cent cholesterol assimilation = ------------------------------------------x 100 per cent
Cholesterol (pg/mL)]oh
Determination of Lactic Acid Production
Cells of probiotic culture were adjusted to OD660 (1010cfu/ml) .Flasks containing 
10 ml of sterile MRS broth were inoculated with test probiotic cells at concentration 
of 1010cfu/ml. The fermentations of flasks were carried out in a shaking incubator 
at 37 ± 1°C for 6 h with shaking speed of 15Og. Aliquots of 5 ml were withdrawn 
from each fermentation flasks (in triplicates) at every 30 min intervals till 4.5 h. The 
aliquots were thermally treated at 95 ± 1 °C for 20 min in a water bath. The thermally 
treated samples were sealed well with parafilm and stored at 4 ± 1 °C. The samples 
were analysed for lactic acid using HPLC (Agilent technologies, 1260 Infinity, 
USA) equipped with a UV-VIS detector HPLC column, PhenomenexRezex™ ROA- 
Organic Acid H+ (8 per cent). The column was 50 mm x 7.8 mm with a length of
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300 mm, 7.8 mm diameter and 8 pm particle sizes. The mobile phase was 0.005 M 
H2S0 4 with an isocratic elution of a flow rate of 0.6 ml/min. the lactic acid content 
vvas quantified by measuring the wave length at 210 nm from the peak area at 
specific retention time for lactic acid and by considering the regression curve factor.
Statistical Analysis
All the experiments mentioned in this paper were repeated twice. The mean 
and the standard error of the data obtained from three parallel experiments were 
calculated using MINITAB 14.
Results and Discussion
Phenotypic Characterization
Four different bacterial strains isolated from fermented finger millet "raavana" 
variety. Among them, gram positive, cocci shaped that grow on MRS agar with 
typical LAB colony characteristics such as punctiform, glistening colony with entire 
margins and raised elevation was selected for further studies. Further, the isolate 
observed to be non-spore forming and non-motile.
Biochem ical Characterization
The isolate demonstrates negative reactions to the biochemical tests including 
catalase, starch hydrolysis, Indole, Voges Proskeur, Methyl Red and citrate utilization 
thus exhibited typical LAB biochemical characteristics. Among the tested sugars, 
it ferments glucose, fructose, maltose, lactose, galactose, sucrose, salicinsorbitol, 
mannitol, cellulose, cellobiose and dextrose. However do not ferment melezitose, 
melibiose, arabinose and ribose.
Genotypic Characterization
The isolate was genotypically identified as Lactococcus lactis subsp. lactis. Partial 
sequence of the 16S rRNAgene of the Sri Lankan strain was deposited in the NCBI 
gene bank as Lactococcus lactis subsp. lactis FM_19LAB and the accession number 
MF480428 was obtained.
In vitro Safety Attributes
Lactococcus lactis subsp. lactis FM_19LAB did not demonstrate hemolysis, 
DNAse and gelatin hydrolysis thus indicating its' safety to use as potential probiotic.
In vitro Probiotic Attributes
Lactococcus lactis subsp. lactis FM_19LAB could tolerate pH 3 and 4 not 2. 
Further, except 2 per cent, the strain could tolerate all the other bile concentrations 
tested. Moreover, it tolerate salt only up to 5 per cent. Lactococcus lactis subsp. lactis 
FM_19LAB could tolerate simulated gastric juice up to pH 4,wheras it did not survive 
in gastric juice containing pH 2 and 3. The isolate tolerate phenol up to 0.2 per cent 
and grow luxuriously in all the tested temperatures (Table 16.1).
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Table 16.1: Probiotic Attributes of Lactococcus lactis subsp. lactis FM_19LAB
Acid (pH) Bile (per cent) Salt (per cent) 
3 4 0.2 0.5 1.0 1.5 2.0 4 5 8 12
G.J(pH) Phenol (per cent) Temp "  
2 3 4 0.1 0.2 0.3 0.4 0.5 30 37 4?
- +  + + +  + + - + + . . - - + +  + - - - + + +
+: Tolerate; Do not tolerate; G.J: Gastric Juice.
Investigating A ntibiotic Su scep tib ility  of Potential Probiotic by 
Alamar Blue Cell Viability Assay
Antibiotic sensitivity/resistance pattern of Lactococcus lactis subsp. lactis 
FM_19LAB is illustrated in the Table 16.2.
Table 16.2: Antibiotic Sensitivity/Resistance Pattern of 
Lactococcus lactis subsp. lactis FM_19LAB
Test Antibiotics 
(100 pg/ml)
Percentage Inhibition (Per cent) of Lactococcus lactis subsp. 
lactis FM_ 19LAB Cells by the Antibiotic
Netilmycin 47.56 ± 1.39
Amikacin 26.97 ±0.34
Gentamycin 14.71 ±0.81
Ofloxacin 14.63 ±0.55
Cefoxitin 19.29 ±0.41
Doxycycline 12.55 ±0.68
Sulbactum 23.66 ± 0.56
Neomycin 37.15 ±0.37
Ampicillin 22.57 ± 0.67
Vancomycin 31.31 ±0.42
Oxycillin 31.81 ±0.78
Streptomycin 42.34 ±0.15
Penicillin 72.83 ± 1.99
Nitrofurantoin 55.36 ± 0.42
Sulfamethoxazole 67.25 ±0.30
Cholramphenicol 19.05 ±0.17
Trimethoprin 22.10 ±0.44
Clindamycin 0.04 ± 0.01
Ciprofloxacin 25.85 ± 0.78
Coistin 35.05 ± 0.84
Ceftazidime 47.09 ±1.13
Nystatin 59.42 ± 2.07
Imipanum 95.70 ±0.35
Tetracycline 24.21 ± 0.66
Data is expresses as mean ± SEM, n=9.
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Results of the antibiotic susceptibility pattern of Lactococcus lactis subsp. 
jj§ FM_19LAB obtained from the Alamar blue assay revealed that, imipanum 
ve the highest inhibitory activity followed by penicillin and sulfamethoxazole, 
furthermore, when the inhibition of test antibiotics observed to be <10 per cent,it 
a^S considered as the strain is potentially resistant to particular antibiotic. Such 
,cenario was only observed in clindamycin that exhibit poorest inhibition of the 
J,robiotic strain.
in vitro Antimicrobial Activity of L. lactis subspp. lactis FM_19LAB
Table 16.3: Antimicrobial Activity of Lactococcus lactis subsp. lactis FM_19LAB 
against Sensitive and Multi Drug Resistant Pathogens
Test Pathogen Antimicrobial Activity of Probiotic Strains 
Diameter of the Zone of Inhibition (in mm)
Drug sensitive organisms
E.coli ATCC 2592 15.33 ±0.33
K. pneumonia ATCC 35594 15.00 ±0.00
S. aureus ATCC 6571 12.66 ±0.33
S. sanguinis ATCC 10556 0.00 ± 0.00
S. satvarius ATCC 13419 16.00 ±0.00
S. flexenari ATCC 12022 16.00 ±0.00
E. faecilis ATCC49532 0.00 ±0.00
A. baumani ATCC 17978 11.33 ± 0.33
S. mutans ATCC 25175 0.00 ± 0.00
S. pyogenes ATCC 700294 12.33 ±0.33
Multi Drug Resistant Organisms (MDR)
E. coli ATCC 35218 18.33 ±0.33
S.aureus 17EMRSA COCR 14.66 ±0.33
__ S.aureus 16 EMRSA NCTC 13143 17.66 ±0.66
__ K.pneumonia ATCC 700603 0.00 ± 0.00
__  E. faecilis ATCC 700802 0.00 ± 0.00
___  S.enterica ATCC 700408 9.66 ±0.88
“>ata is expresses as mean ± SEM, n=9.
Among the drug sensitive pathogens, Lactococcus lactis subsp. lactis FM_19LAB 
emonstrated highest inhibition in S. salvarius ATCC 13419 andS. flexenari ATCC 
2022.Whereas, it did not inhibit S. mutansATCC 25175. Among the MDR pathogens, 
^ctococcus lactis subsp. lactis FM_19LAB demonstrated highestinhibition in E. 
-o/iATCC 35218 followed by S.aureus 16 EMRSA NCTC 13143. Whereas, it did not 
^hibit K.pneumonia ATCC 700603 and E.faecilis ATCC 700802.
As reported by many authors, the antimicrobial activity is one of the most 
important selection criteria for probiotics. Where, probiotics compete with other 
r>fectious bacteria for nutrients and cell surface (Quwehand and Vesterlund, 2004, 
£ a kv r. 2003: Rodrieuez et al., 2 0 0 3 ) .Therefore, the results of the antimicrobial
activity of the Lactococcus lactis subsp. lactis FM_19LAB revealed its'ability to inhijj- 
both drug sensitive and multi drug resistant human pathogens that are causj^ 
infections in the gastrointestinal track, respiratory track as well as in the skin. Thu  ^
provide information regarding it's' potentiality to use them in novel th erap e^  
food developments. Furthermore, the stranded drug imipeum used as the control 
with every experiment and it demonstrated highest antimicrobial activity against 
every tested pathogen.
In vitro Anti-cancer Activity of L. lactis subspp. lactis FM_19LAB
The anticancer activity of L. lactis subsp. plactis FM_19LAB observed to increase 
with increasing the concentration of CFE and CFL. Further, both CFE and CFL of 
lactis sub spplactis FM_19LAB inhibit HT 29 cell line than HCT 116 (Table 16.4).
Table 16.4: Results of the Anticancer Activity of different Concentrations of 
Lactococcus lactis subsp. lactis FM_19LABCFE and 
CFL Values against HT 29 and HCT 116 Cell Line
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Percentage inhibition (per cent) of HT 29 cell line by test probiotic CFE at different concentrations
5 (jl/ml 25 |jl/ml 50 pl/ml 250 pl/ml 500 pl/ml ic5„
6.23 ± 1.62 16.20 ±3.78 51.55 ±3.66 65.97 ±1.13 80.11 ±0.58 247.12 ±4.68
Percentage inhibition (per cent) of HT 29 cell line by test probiotic CFL at different concentrations
1250 pg/ml 2500 pg/ml 3750 Mg/ml 5000 pg/ml 7500 pg/ml ic.
31.37 ± 1.73 39.89 ± 3.08 50.23 ± 0.46 76.46 ± 1.64 95.99 ± 0.49 3267.6 ± 76.2
Percentage inhibition (per cent) of HCT 116 cell line by test probiotic
CFE at different concentrations
5 pl/ml 25 til/ml 50 pl/ml 250 pl/ml 500 pl/ml icso
0.00 ± 0.00 13.80 ± 1.80 20.87 ± 0.77 63.19 ±2.26 73.16 ±0.60 319.43 ±3.74
Percentage inhibition (per cent) of HCT 116 cell line by test probiotic
CFL at different concentrations
1250 |jg/ml 2500 ng/ml 3750 pg/ml 5000 pg/ml 7500 pg/ml ic5„
10.15 ±0.45 21.15 ±0.45 52.46 ±1.98 73.16 ±0.60 87.15 ±0.71 4174.0 ±3.03
Data is expresses as mean ± SEM, n=9.
DPPH R ad ica l Scavenging A ctivity of L. lactis subspp. lactis 
FM_19LAB
It was observed that the DPPH radical scavenging activity of L. lactis subsp- 
plactis FM_19LAB increased with the increment of both CFE and CFL (Figures 16-1 
and 16.2).
In vitro Cholesterol of L. lactis subspp. lactis FM_19LAB
Lactococcus lactis subsp. lactis FM_19LAB observed to be weak cholesterol 
assimilator that assimilated 4.42 per cent of cholesterol in the growth medium- 
As reported by many authors, the cholesterol lowering effect is one of the most 
important selection criteria for probiotics thus can accept as an alternative therapy 
for treating hyperlipidemia (Homayouni et al., 2012). Although test probiotic do
5 (il/ml 25jil/ml 50|il/ml 250jil/ml 500nl/ml
Concentrations of CFE (in {til/ml)
Figure 16.1: DPPH Radical Scavenging Activity of Lactococcus lactis subsp. lactis 
FM_19LAB CFE (Data is expresses as mean ± SEM, n=9).
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Figure 16.2: DPPH Radical Scavenging Activity of Lactococcus lactis subsp. lactis 
FM_19LAB CFL (Data is expresses as mean ± SEM, n=9).
not effective in removing cholesterol as a standard drug; however the results of the 
cholesterol assimilation of the test probiotic used in this study revealed its' ability 
to assimilate cholesterol at 1010cfu/ml concentration. Thus, provide information 
regarding its' potentiality to use them in novel therapeutic food developments.
In vitro Lactic Acid Production by L. lactis subspp. lactis FM_19LAB
Lactic acid is a commercially important organic acids produced by LAB. 
Furthermore, lactic acid contributes food preservation as well as exerts antagonistic 
effect against human pathogenic microorganisms (Asmahan Ali, 2010). Therefore, 
ability to produce lactic acid is one of the important criteria of probiotics to become 
commercially successful starter cultures. It was observed that, at the end of the 
fermentation period, Lactococcus lactis subsp. lactis FM_19LAB produced 4.62±
0.07 mg/ml lactic acid. Further, it was observed that, the lactic acid synthesis was 
increased with the time (Figure 16.3).
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Figure 16.3: Lactic Acid Production by L. lactis subspp. lactis FM_19LAB (Data is 
expresses as mean ± SEM, n=9).
Conclusion
This study concludes that Lactococcus lactis subsp. lactis FM_19LAB isolated from 
Sri Lankan grown finger millet var. Raavana has probiotic attributes, in vitro safety 
properties as well as in vitro efficacy. However, the strain needs to be investigated 
for its' in-vivo oral and geno toxicity prior to commercial applications. This is the 
first report on isolation and characterisation of probiotic potential Lactococcusspp 
from Sri Lankan finger millet variety 'Raavana'.
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